000 01411 a2200373 4500
005 20250516180016.0
264 0 _c20140707
008 201407s 0 0 eng d
022 _a1558-3163
024 7 _a10.1016/j.rdc.2013.05.003
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFoeldvari, Ivan
245 0 0 _aNew developments in juvenile systemic and localized scleroderma.
_h[electronic resource]
260 _bRheumatic diseases clinics of North America
_cNov 2013
300 _a905-20 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAntibodies, Monoclonal, Humanized
_xtherapeutic use
650 0 4 _aChild
650 0 4 _aGlucocorticoids
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aImmunosuppressive Agents
_xtherapeutic use
650 0 4 _aMethotrexate
_xtherapeutic use
650 0 4 _aMicroscopic Angioscopy
650 0 4 _aMycophenolic Acid
_xanalogs & derivatives
650 0 4 _aScleroderma, Localized
_xcomplications
650 0 4 _aScleroderma, Systemic
_xcomplications
650 0 4 _aSkin
_xdiagnostic imaging
650 0 4 _aThermography
650 0 4 _aTomography, Optical Coherence
650 0 4 _aUltrasonography, Doppler
650 0 4 _aUveitis
_xdiagnosis
773 0 _tRheumatic diseases clinics of North America
_gvol. 39
_gno. 4
_gp. 905-20
856 4 0 _uhttps://doi.org/10.1016/j.rdc.2013.05.003
_zAvailable from publisher's website
999 _c23222533
_d23222533